MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
Suggest Documents
Hepatocyte growth factor signalizes peritoneal membrane failure in peritoneal dialysis.
Anatomy and physiology of the peritoneal membrane.
Evaluation of peritoneal membrane pore models.
Pharmacologic targets and peritoneal membrane remodeling.
Letter: Plasmapheresis and immunostimulation.
Plasmapheresis in severe asthma.
Plasmapheresis in Raynaud's disease.
Sustained low peritoneal effluent CCL18 levels are associated with preservation of peritoneal membrane function in peritoneal dialysis.
The first peritonitis episode alters the natural course of peritoneal membrane characteristics in peritoneal dialysis patients.
Plasmapheresis for lupus nephritis.
Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis.
Correction: Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis.
Plasmapheresis and myasthenia gravis.
Plasma exchange and plasmapheresis.
Plasmapheresis in macroglobulinaemia.
Plasmapheresis in severe asthma.
Plasmapheresis in severe asthma.
Plasmapheresis: technique and complications.
Purification of plasma membrane of guinea pig peritoneal macrophages.
Net fluid absorption under membrane transport models of peritoneal dialysis.
Plasmapheresis in Raynaud's disease.
Plasmapheresis in Crohn's disease.
Volume limitations of plasmapheresis.
Goodpasture's syndrome--effects of plasmapheresis.
Peritoneal membrane plasmapheresis.
A novel process has been devised that uses the peritoneal membrane to remove plasma proteins from the body at a rate comparable to conventional extrac...
333KB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Hepatocyte growth factor signalizes peritoneal membrane failure in peritoneal dialysis.
Anatomy and physiology of the peritoneal membrane.
Evaluation of peritoneal membrane pore models.
Pharmacologic targets and peritoneal membrane remodeling.
Letter: Plasmapheresis and immunostimulation.
Plasmapheresis in severe asthma.
Plasmapheresis in Raynaud's disease.
Sustained low peritoneal effluent CCL18 levels are associated with preservation of peritoneal membrane function in peritoneal dialysis.
The first peritonitis episode alters the natural course of peritoneal membrane characteristics in peritoneal dialysis patients.
Plasmapheresis for lupus nephritis.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms
